Jason M. Pogue

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19”.

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Clinical Infectious Diseases(2020)10.1093/cid/ciaa954

N/A

0.933DataRank · unranked

501 citations

Gregory Eschenauer, Jonathan P. Troost, Jonathan L. Golob, Tejal Gandhi, Lu Wang +17 more

ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study

JMIR mhealth and uhealth(2020)10.2196/20525

N/A

0DataRank · unranked

5 citations

Chen Li, Jason M. Pogue, Varun Sharma, Ilias Karaiskos, Keith S. Kaye +6 more

Recommended Revisions to the National SEP‐1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2020)10.1002/phar.2384

N/A

0DataRank · unranked

1 citations

Samuel L Aitken, David E. Nix, Richard H. Drew, Warren E. Rose, Susan L. Davis +5 more

Tocilizumab for treatment of mechanically ventilated patients with COVID-19

medRxiv(2020)10.1101/2020.05.29.20117358

N/A

0DataRank · unranked

128 citations

Gregory Eschenauer, Jonathan P. Troost, Jonathan L. Golob, Tejal Gandhi, Lu Wang +17 more

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals

Antimicrobial Stewardship & Healthcare Epidemiology(2022)10.1017/ash.2022.248

N/A

0DataRank · unranked

2 citations

Hita Bhagat, Robbie Christian, Carlos del Rı́o, Kenneth C. Hohmeier, Michael E. Klepser +2 more

A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients

Clinical Microbiology and Infection(2023)10.1016/j.cmi.2023.05.018

N/A

0DataRank · unranked

25 citations

Andrea Lay‐Hoon Kwa, Alexandre Prehn Zavascki, Ana Maria Sandri, Marc H. Scheetz, Christine J. Kubin +14 more

Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia

Clinical Infectious Diseases(2024)10.1093/cid/ciae332

N/A

0DataRank · unranked

29 citations

Ellen G Kline, Ghady Haidar, Kevin M Squires, Jason M. Pogue, Erin K. McCreary +6 more

The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States—Is There a Potential Role for Durlobactam?

Clinical Infectious Diseases(2024)10.1093/cid/ciae229

N/A

0DataRank · unranked

20 citations

Virginia Pierce, Jason M. Pogue, Ellen G Kline, Frank Tverdek, Ryan K. Shields +1 more

Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3729

N/A

0DataRank · unranked

4 citations

Ramya Mahadevan, Gauri G. Rao, Alexandre Prehn Zavascki, Ana Maria Sandri, Andrea Lay‐Hoon Kwa +15 more